Production (Stage)
Sensus Healthcare, Inc.
SRTS
$4.69
$0.010.21%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -21.75% | 3.97% | 126.76% | 104.09% | 212.33% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -21.75% | 3.97% | 126.76% | 104.09% | 212.33% |
| Cost of Revenue | -0.27% | 25.84% | 88.53% | 100.00% | 123.27% |
| Gross Profit | -34.64% | -9.26% | 163.45% | 107.06% | 310.73% |
| SG&A Expenses | 54.23% | 142.17% | 2.89% | -11.94% | -17.73% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 41.33% | 62.23% | 26.77% | 28.35% | 22.40% |
| Operating Income | -191.65% | -69.05% | 178.89% | 275.87% | 198.23% |
| Income Before Tax | -179.39% | -66.30% | 212.56% | 348.41% | 215.02% |
| Income Tax Expenses | -86.70% | -74.29% | 547.20% | 215.34% | 203.12% |
| Earnings from Continuing Operations | -213.10% | -63.28% | 183.74% | 524.21% | 220.06% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -213.10% | -63.28% | 183.74% | 524.21% | 220.06% |
| EBIT | -191.65% | -69.05% | 178.89% | 275.87% | 198.23% |
| EBITDA | -186.57% | -67.87% | 184.36% | 292.82% | 203.18% |
| EPS Basic | -212.75% | -63.43% | 183.41% | 522.65% | 219.73% |
| Normalized Basic EPS | -179.23% | -66.46% | 209.16% | 347.79% | 214.66% |
| EPS Diluted | -214.61% | -63.43% | 177.78% | 522.65% | 216.33% |
| Normalized Diluted EPS | -179.29% | -66.64% | 209.00% | 347.20% | 214.56% |
| Average Basic Shares Outstanding | 0.29% | 0.39% | 0.31% | 0.30% | 0.31% |
| Average Diluted Shares Outstanding | 0.15% | 1.04% | 0.46% | 0.52% | 0.45% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |